Initial Treatment for Focal Seizures
For adults with newly diagnosed focal seizures, the first-line treatment options are lamotrigine or oxcarbazepine, with levetiracetam as an alternative if there is no history of psychiatric disorders. 1
Understanding Focal Seizures
Focal seizures affect only one area of the brain and can present as:
- Jerking of one extremity or one side of the body
- Abnormal facial movements
- Small repetitive movements
- Staring spells (focal impaired awareness)
- With or without changes in consciousness 2
Some focal seizures may progress to generalized seizures, and they can last from seconds to hours, typically followed by a postictal period of tiredness and confusion.
First-Line Treatment Options
Recommended Medications
Lamotrigine:
Oxcarbazepine:
- Considered first-line therapy for focal epilepsy 1
- Better tolerability profile than older agents like carbamazepine
Levetiracetam:
Treatment Algorithm
Initial Assessment:
- Confirm focal seizure diagnosis through clinical history, EEG, and neuroimaging
- Evaluate for underlying causes (tumors, infection, stroke, trauma)
- Determine if treatment should be initiated (generally after 2 unprovoked seizures or 1 with risk factors)
Medication Selection Factors:
- Patient age and sex
- Comorbidities (especially psychiatric disorders)
- Potential drug interactions
- Pregnancy potential in women of childbearing age
- Side effect profiles
Starting Therapy:
- Begin with low dose and titrate slowly to minimize side effects
- Target the lowest effective dose for seizure control
- Monitor for adverse effects and seizure control
Monitoring and Follow-up
- Regular follow-up to assess seizure control
- Monitor for adverse effects
- Consider EEG monitoring if clinical response is inadequate
- Evaluate need for dose adjustments based on response
Common Adverse Effects to Monitor
- Lamotrigine: Rash (including serious skin reactions), dizziness, headache
- Oxcarbazepine: Hyponatremia, dizziness, fatigue, gastrointestinal disturbances
- Levetiracetam: Behavioral changes, irritability, fatigue, dizziness
Important Considerations and Pitfalls
Avoid enzyme-inducing antiepileptic drugs (carbamazepine, phenytoin) as first-line in patients with cardiovascular comorbidities as they may worsen hyperlipidemia and accelerate metabolism of cardiovascular medications 1
Caution with levetiracetam in patients with history of psychiatric disorders due to potential behavioral side effects
Avoid rapid titration of lamotrigine as it increases risk of serious rash
Do not use valproate as first-line for focal seizures as it has higher treatment failure rates compared to lamotrigine 3
Medication adherence is crucial for seizure control - educate patients about importance of consistent dosing
Approximately 60-70% of patients can achieve seizure freedom with appropriate medication 1, but this requires careful selection and monitoring of therapy